Trans Genic Inc. (2342.T)
JPY 159.0
(17.78%)
JPY 159.0
(17.78%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -392.45 Million | -1.43 Billion | 1.78 Billion | 1.22 Billion | -20 Million |
| Net Income | 43.08 Million | -331.8 Million | 2.76 Billion | 695.2 Million | -440 Million |
| Depreciation & Amortization | 150.39 Million | 183.51 Million | 227.96 Million | 251.46 Million | 229 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -698.58 Million | -812.26 Million | 35.85 Million | 232.33 Million | -190 Million |
| Other non-cash items | 75.78 Million | -202.31 Million | -382.38 Million | -41.84 Million | 381 Million |
| Investing Cash Flow | -280.92 Million | -216.01 Million | 981.86 Million | 48.43 Million | -318 Million |
| Investments in PPE | -265.66 Million | -306.27 Million | -532.05 Million | -145.8 Million | -256 Million |
| Acquisitions | 7.81 Million | -728.31 Million | 1.25 Billion | -42.07 Million | -85 Million |
| Investment purchases | -12.08 Million | -15 Million | - | -101.2 Million | - |
| Sales/Maturities of investments | 22.89 Million | 708.89 Million | 43.21 Million | 251.66 Million | 57.37 Million |
| Other Investing Activities | -33.89 Million | -4.45 Million | 215.9 Million | -16.1 Million | 23 Million |
| Financing Cash Flow | -342.68 Million | 484.98 Million | -1.18 Billion | 10.03 Million | 666 Million |
| Debt repayment | -146.39 Million | -619.52 Million | -741.08 Million | -183.57 Million | -615 Million |
| Dividends payments | -83.81 Million | -100.9 Million | -52.1 Million | - | - |
| Common Stock Repurchased | -78.61 Million | - | -298.59 Million | -10 Million | -3.85 Million |
| Common Stock Issuance | - | - | - | - | 4.88 Million |
| Other Financing Activities | -16.13 Million | -16.13 Million | -73.94 Million | -145.88 Million | 51 Million |
| Accounts receivables | -259 Million | -115 Million | 123 Million | -85 Million | -121 Million |
| Accounts payables | -132.6 Million | 87.43 Million | -102.53 Million | 34.76 Million | 96.33 Million |
| Inventory | 10.57 Million | -467.66 Million | -353.43 Million | -118.2 Million | -120 Million |
| Other working capital | -246 Million | -29 Million | -51 Million | 135 Million | 51 Million |
| Cash at beginning of period | 3.45 Billion | 4.61 Billion | 3.03 Billion | 1.6 Billion | 1.27 Billion |
| Cash at end of period | 2.46 Billion | 3.45 Billion | 4.61 Billion | 3.03 Billion | 327 Million |
| Capital Expenditure | -265.66 Million | -306.27 Million | -532.05 Million | -145.8 Million | -256 Million |
| Effect of forex changes on cash | 22.72 Million | 1.99 Million | 498 Thousand | -493 Thousand | -1 Million |
| Net cash flow / Change in cash | -993.34 Million | -1.15 Billion | 1.58 Billion | 1.42 Billion | -950.52 Million |
| Free Cash Flow | -658.12 Million | -1.73 Billion | 1.25 Billion | 1.07 Billion | -276 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -99 Million | 42 Million | 43.08 Million | -86 Million | -30 Million | 78 Million |
| Depreciation & Amortization | - | - | 150.39 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -698.58 Million | - | - | - |
| Other non-cash items | 99 Million | -42 Million | 75.78 Million | 86 Million | 30 Million | -78 Million |
| Investing Cash Flow | - | - | -280.92 Million | - | - | - |
| Investments in PPE | - | - | -265.66 Million | - | - | - |
| Acquisitions | - | - | 7.81 Million | - | - | - |
| Investment purchases | - | - | -12.08 Million | - | - | - |
| Sales/Maturities of investments | - | - | 22.89 Million | - | - | - |
| Other Investing Activities | - | - | -33.89 Million | - | - | - |
| Financing Cash Flow | - | - | -342.68 Million | - | - | - |
| Debt repayment | - | - | -146.39 Million | - | - | - |
| Dividends payments | - | - | -83.81 Million | - | - | - |
| Common Stock Repurchased | - | - | -78.61 Million | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | -16.13 Million | - | - | - |
| Accounts receivables | - | - | -259 Million | - | - | - |
| Accounts payables | - | - | -132.6 Million | - | - | - |
| Inventory | - | - | 10.57 Million | - | - | - |
| Other working capital | - | - | -246 Million | - | - | - |
| Cash at beginning of period | - | - | 3.45 Billion | - | - | - |
| Cash at end of period | - | - | 2.46 Billion | - | - | - |
| Capital Expenditure | - | - | -265.66 Million | - | - | - |
| Effect of forex changes on cash | - | - | 22.72 Million | - | - | - |
| Net cash flow / Change in cash | - | - | -993.34 Million | - | - | - |
| Free Cash Flow | - | - | -658.12 Million | - | - | - |
BYON
4027
PPRO
PZZA
MANORAMA
2390